Abatacept



Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 63.9%
Systemic Lupus Erythematosus 10.9%
Crohn's Disease 3.1%
Prophylaxis 3.0%
Hypertension 3.0%
Colitis Ulcerative 2.2%
Osteoporosis 2.0%
Gastritis 1.6%
Gastritis Prophylaxis 1.6%
Polyarthritis 1.0%
Convulsion 0.9%
Depression 0.9%
Constipation 0.8%
Juvenile Arthritis 0.8%
Neuropathy Peripheral 0.8%
Asthenopia 0.7%
Asthma 0.7%
Pain 0.7%
Urticaria Chronic 0.7%
Ankylosing Spondylitis 0.7%
Pyrexia 9.3%
Pneumonia 8.2%
Sepsis 8.2%
Vomiting 7.5%
Urinary Tract Infection 6.7%
Septic Shock 6.3%
Crohn's Disease 6.0%
Gastroenteritis 5.6%
Anaemia 5.2%
Osteonecrosis 4.9%
Colitis Ulcerative 4.5%
Subcutaneous Abscess 4.1%
Renal Failure 3.4%
Appendicitis 3.0%
Convulsion 3.0%
Interstitial Lung Disease 3.0%
Psoriasis 3.0%
Renal Failure Acute 3.0%
Cholecystitis 2.6%
Dyspnoea 2.6%
Secondary
Rheumatoid Arthritis 61.8%
Product Used For Unknown Indication 12.5%
Drug Use For Unknown Indication 6.2%
Hypertension 3.4%
Systemic Lupus Erythematosus 3.0%
Polyarthritis 2.8%
Diabetes Mellitus 1.3%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Gastritis Prophylaxis 1.0%
Juvenile Arthritis 1.0%
Prophylaxis 0.8%
Hyperlipidaemia 0.7%
Inflammation 0.7%
Osteoporosis 0.7%
Psoriatic Arthropathy 0.6%
Seronegative Rheumatoid Arthritis 0.6%
Blood Cholesterol 0.5%
Cardiovascular Event Prophylaxis 0.5%
Hypothyroidism 0.5%
Mineral Supplementation 0.5%
Breast Cancer 8.1%
Cellulitis 8.1%
Gastric Cancer 8.1%
Lung Adenocarcinoma Metastatic 8.1%
Breast Cancer In Situ 7.0%
Sepsis 7.0%
Appendicitis 5.8%
Basal Cell Carcinoma 5.8%
Colon Cancer Metastatic 4.7%
Lung Adenocarcinoma 4.7%
Pulmonary Embolism 4.7%
Cholecystitis 3.5%
Nasopharyngitis 3.5%
Pneumonia 3.5%
Prostate Cancer 3.5%
Urticaria 3.5%
Ventricular Extrasystoles 3.5%
Abscess Oral 2.3%
Autoimmune Hepatitis 2.3%
Bladder Transitional Cell Carcinoma 2.3%
Concomitant
Rheumatoid Arthritis 43.0%
Product Used For Unknown Indication 27.3%
Drug Use For Unknown Indication 7.9%
Polyarthritis 3.7%
Hyperlipidaemia 2.4%
Prophylaxis Against Graft Versus Host Disease 2.4%
Hypertension 1.8%
Arthralgia 1.6%
Medical Diet 1.6%
Hyperuricaemia 1.0%
Infection Prophylaxis 1.0%
Blood Cholesterol Abnormal 0.8%
Cardiovascular Event Prophylaxis 0.8%
Glaucoma 0.8%
Pain 0.8%
Rhinitis Seasonal 0.8%
Vitamin Supplementation 0.8%
Diabetes Mellitus 0.5%
Insomnia 0.5%
Musculoskeletal Pain 0.5%
Graft Versus Host Disease 8.8%
Thrombocytopenia 8.8%
Weight Decreased 8.8%
Articular Calcification 5.9%
Chronic Obstructive Pulmonary Disease 5.9%
Cytolytic Hepatitis 5.9%
Diarrhoea 5.9%
Herpes Zoster 5.9%
Meningitis Meningococcal 5.9%
Pneumocystis Jiroveci Pneumonia 5.9%
Pulmonary Mass 5.9%
Agranulocytosis 2.9%
Angina Pectoris 2.9%
Arthralgia 2.9%
Autoimmune Hepatitis 2.9%
Bladder Transitional Cell Carcinoma 2.9%
Blindness Unilateral 2.9%
C-reactive Protein Increased 2.9%
Cholelithiasis 2.9%
Conjunctival Haemorrhage 2.9%